MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells

Abstract Therapies targeting epigenetic changes for cancer treatment are in Phase I/II trials; however, all of these target only nuclear DNA. Emerging evidence suggests presence of methylation marks on mitochondrial DNA (mtDNA); but their contribution in cancer is unidentified. Expression of genes e...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Malav Trivedi, Amit Singh, Meghna Talekar, Grishma Pawar, Parin Shah, Mansoor Amiji
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2017
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/f6288c51414948cfa657e839016a80ed
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f6288c51414948cfa657e839016a80ed
record_format	dspace
spelling	oai:doaj.org-article:f6288c51414948cfa657e839016a80ed2021-12-02T15:04:57ZMicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells10.1038/s41598-017-02816-82045-2322https://doaj.org/article/f6288c51414948cfa657e839016a80ed2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-02816-8https://doaj.org/toc/2045-2322Abstract Therapies targeting epigenetic changes for cancer treatment are in Phase I/II trials; however, all of these target only nuclear DNA. Emerging evidence suggests presence of methylation marks on mitochondrial DNA (mtDNA); but their contribution in cancer is unidentified. Expression of genes encoded on mtDNA are altered in cancer cells, along with increased glycolytic flux. Such glycolytic flux and elevated reactive oxygen species is supported by increased antioxidant; glutathione. MicroRNA-34a can translocate to mitochondria, mediate downstream apoptotic effects of tumor suppressor P53, and inhibit the antioxidant response element Nrf-2, resulting in depleted glutathione levels. Based on such strong rationale, we encapsulated microRNA-34a in our well-established Hyaluronic-Acid nanoparticles and delivered to cisplatin-sensitive and cisplatin-resistant A549-lung adenocarcinoma cells. Successful delivery and uptake in cells resulted in altered ATP levels, decreased glycolytic flux, Nrf-2 and glutathione levels, ultimately resulting in caspase-3 activation and apoptosis. Most important were the concurrent underlying molecular changes in epigenetic status of D-loop on the mtDNA and transcription of mtDNA-encoded genes. Although preliminary, we provide a novel therapeutic approach in form of altered mitochondrial bioenergetics and redox status of cancer cells with underlying changes in epigenetic status of mtDNA that can subsequently results in induction of cancer cell apoptosis.Malav TrivediAmit SinghMeghna TalekarGrishma PawarParin ShahMansoor AmijiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-17 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Malav Trivedi Amit Singh Meghna Talekar Grishma Pawar Parin Shah Mansoor Amiji MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells
description	Abstract Therapies targeting epigenetic changes for cancer treatment are in Phase I/II trials; however, all of these target only nuclear DNA. Emerging evidence suggests presence of methylation marks on mitochondrial DNA (mtDNA); but their contribution in cancer is unidentified. Expression of genes encoded on mtDNA are altered in cancer cells, along with increased glycolytic flux. Such glycolytic flux and elevated reactive oxygen species is supported by increased antioxidant; glutathione. MicroRNA-34a can translocate to mitochondria, mediate downstream apoptotic effects of tumor suppressor P53, and inhibit the antioxidant response element Nrf-2, resulting in depleted glutathione levels. Based on such strong rationale, we encapsulated microRNA-34a in our well-established Hyaluronic-Acid nanoparticles and delivered to cisplatin-sensitive and cisplatin-resistant A549-lung adenocarcinoma cells. Successful delivery and uptake in cells resulted in altered ATP levels, decreased glycolytic flux, Nrf-2 and glutathione levels, ultimately resulting in caspase-3 activation and apoptosis. Most important were the concurrent underlying molecular changes in epigenetic status of D-loop on the mtDNA and transcription of mtDNA-encoded genes. Although preliminary, we provide a novel therapeutic approach in form of altered mitochondrial bioenergetics and redox status of cancer cells with underlying changes in epigenetic status of mtDNA that can subsequently results in induction of cancer cell apoptosis.
format	article
author	Malav Trivedi Amit Singh Meghna Talekar Grishma Pawar Parin Shah Mansoor Amiji
author_facet	Malav Trivedi Amit Singh Meghna Talekar Grishma Pawar Parin Shah Mansoor Amiji
author_sort	Malav Trivedi
title	MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells
title_short	MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells
title_full	MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells
title_fullStr	MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells
title_full_unstemmed	MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells
title_sort	microrna-34a encapsulated in hyaluronic acid nanoparticles induces epigenetic changes with altered mitochondrial bioenergetics and apoptosis in non-small-cell lung cancer cells
publisher	Nature Portfolio
publishDate	2017
url	https://doaj.org/article/f6288c51414948cfa657e839016a80ed
work_keys_str_mv	AT malavtrivedi microrna34aencapsulatedinhyaluronicacidnanoparticlesinducesepigeneticchangeswithalteredmitochondrialbioenergeticsandapoptosisinnonsmallcelllungcancercells AT amitsingh microrna34aencapsulatedinhyaluronicacidnanoparticlesinducesepigeneticchangeswithalteredmitochondrialbioenergeticsandapoptosisinnonsmallcelllungcancercells AT meghnatalekar microrna34aencapsulatedinhyaluronicacidnanoparticlesinducesepigeneticchangeswithalteredmitochondrialbioenergeticsandapoptosisinnonsmallcelllungcancercells AT grishmapawar microrna34aencapsulatedinhyaluronicacidnanoparticlesinducesepigeneticchangeswithalteredmitochondrialbioenergeticsandapoptosisinnonsmallcelllungcancercells AT parinshah microrna34aencapsulatedinhyaluronicacidnanoparticlesinducesepigeneticchangeswithalteredmitochondrialbioenergeticsandapoptosisinnonsmallcelllungcancercells AT mansooramiji microrna34aencapsulatedinhyaluronicacidnanoparticlesinducesepigeneticchangeswithalteredmitochondrialbioenergeticsandapoptosisinnonsmallcelllungcancercells
_version_	1718388992631635968

MicroRNA-34a Encapsulated in Hyaluronic Acid Nanoparticles Induces Epigenetic Changes with Altered Mitochondrial Bioenergetics and Apoptosis in Non-Small-Cell Lung Cancer Cells

Ejemplares similares